Skip to main content

COVID-19 Topic Center

Expert Insights

Video
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…
Interview
By Julie Gould  Richard Miller, MD, board-certified oncologist and adjunct clinical professor of Medicine (oncology) at Stanford University Medical Center, discusses a trial examining the use of CPI-006, a humanized monoclonal antibody that is designed to bind to and activate B cells, for the…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 2, Issue 2 “…pressure…pushing down on me, pressing down on you…” Under Pressure is certainly as true today as ever, as hypertension continues to inflict a ghastly toll on the adult American population. Using the most recent…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS Volume 2, Issue 1 “Searching for INSPIRATION in all the wrong places.” When trying to talk your way out of a “sticky” situation, nothing helps more than being equipped with the latest and greatest evidence. Unfortunately, when it…
Commentary
By Ken Cahill, CEO and co-founder of SilverCloud Health The COVID-19 pandemic has brought to light many pain points within the healthcare system which need to be addressed. One of those near the top of the list is our approach to mental health treatment. Mental health symptoms for millions have…
Video
Michael Ganio, PharmD, senior director of Pharmacy Practice and Quality, ASHP, breaks down the importance of centralized leadership and clear onsite roles within mass COVID-19 vaccine locations, highlighting the pitfalls that should be avoided during the setup of these sites and how to prevent…
Commentary
By Merissa Andersen, PharmD, MPH Large volume parenterals (LVPs) are premixed solutions of 100mL or greater that are provided in ready to use dosage forms. These premixed solutions are intended to reduce the potential for compounding errors and provide a sterile product labeled with ingredients…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 1, Issue 4 The saga of fish oils products, which are commonly comprised of various omega-3 fatty acid preparations, is a long and serpentine one which is both perpetually bolstered by optimism while simultaneously marred by…
Commentary
Psychiatric disease affects approximately 51 million U.S. citizens (20.6% of U.S. Adults) per year.1 Schizophrenia is a chronic severe neurological brain disorder estimated to affect 1.1 percent of the population or approximately 2.6 million adults in the United States aged 18 or older. An…
Commentary
By Ashley Chiara, PharmD, clinical pharmacy consultant, Clinical Pharmacy Services, University of Massachusetts Medical School Unlike many costly speciality medications and gene therapies requiring diligent financial forecasting, antidepressants do not fit the typical description of a “high-cost”…
Back to Top